The Equine Eye Clinic Limited 10634980 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true 10634980 2024-04-01 2025-03-31 10634980 2025-03-31 10634980 bus:Director3 1 2025-03-31 10634980 core:AcceleratedTaxDepreciationDeferredTax 2025-03-31 10634980 core:HirePurchaseContracts core:CurrentFinancialInstruments 2025-03-31 10634980 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2025-03-31 10634980 core:CurrentFinancialInstruments 2025-03-31 10634980 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 10634980 core:Non-currentFinancialInstruments core:AfterOneYear 2025-03-31 10634980 core:FurnitureFittingsToolsEquipment 2025-03-31 10634980 core:MotorVehicles 2025-03-31 10634980 bus:SmallEntities 2024-04-01 2025-03-31 10634980 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 10634980 bus:FilletedAccounts 2024-04-01 2025-03-31 10634980 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10634980 bus:RegisteredOffice 2024-04-01 2025-03-31 10634980 bus:CompanySecretaryDirector1 2024-04-01 2025-03-31 10634980 bus:Director2 2024-04-01 2025-03-31 10634980 bus:Director3 2024-04-01 2025-03-31 10634980 bus:Director3 1 2024-04-01 2025-03-31 10634980 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10634980 core:ComputerEquipment 2024-04-01 2025-03-31 10634980 core:FurnitureFittings 2024-04-01 2025-03-31 10634980 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 10634980 core:MotorVehicles 2024-04-01 2025-03-31 10634980 core:PlantMachinery 2024-04-01 2025-03-31 10634980 core:KeyManagementPersonnel 2024-04-01 2025-03-31 10634980 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2024-04-01 2025-03-31 10634980 countries:EnglandWales 2024-04-01 2025-03-31 10634980 2024-03-31 10634980 bus:Director3 1 2024-03-31 10634980 core:FurnitureFittingsToolsEquipment 2024-03-31 10634980 core:MotorVehicles 2024-03-31 10634980 2023-04-01 2024-03-31 10634980 2024-03-31 10634980 bus:Director3 1 2024-03-31 10634980 core:HirePurchaseContracts core:CurrentFinancialInstruments 2024-03-31 10634980 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2024-03-31 10634980 core:CurrentFinancialInstruments 2024-03-31 10634980 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 10634980 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 10634980 core:FurnitureFittingsToolsEquipment 2024-03-31 10634980 core:MotorVehicles 2024-03-31 10634980 bus:Director3 1 2023-04-01 2024-03-31 10634980 bus:Director3 1 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 10634980

Prepared for the registrar

The Equine Eye Clinic Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2025

 

The Equine Eye Clinic Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 9

 

The Equine Eye Clinic Limited

Company Information

Directors

Mr T N L Knott

Mrs M Knott

Company secretary

Mrs M Knott

Registered office

Old Bournstream House
Bournstream
Wotton-Under-Edge
Gloucestershire
GL12 7PA

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

The Equine Eye Clinic Limited

(Registration number: 10634980)
Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

29,814

463

Current assets

 

Debtors

5

45,810

48,857

Cash at bank and in hand

 

17,321

21,345

 

63,131

70,202

Creditors: Amounts falling due within one year

6

(23,673)

(15,928)

Net current assets

 

39,458

54,274

Total assets less current liabilities

 

69,272

54,737

Creditors: Amounts falling due after more than one year

6

(24,206)

-

Deferred tax liabilities

8

145

-

Net assets

 

45,211

54,737

Capital and reserves

 

Called up share capital

200

200

Retained earnings

45,011

54,537

Shareholders' funds

 

45,211

54,737

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 12 December 2025 and signed on its behalf by:
 


Mr T N L Knott
Director


Mrs M Knott
Company secretary and director

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Old Bournstream House
Bournstream
Wotton-Under-Edge
Gloucestershire
GL12 7PA

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

15% straight line

Plant and machinery

33.33% straight line

Computer equipment

50% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the Balance Sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the Profit and Loss Account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2024 - 2).

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost

At 1 April 2024

30,646

-

30,646

Additions

1,395

36,240

37,635

At 31 March 2025

32,041

36,240

68,281

Depreciation

At 1 April 2024

30,183

-

30,183

Charge for the year

734

7,550

8,284

At 31 March 2025

30,917

7,550

38,467

Carrying amount

At 31 March 2025

1,124

28,690

29,814

At 31 March 2024

463

-

463

 

5

Debtors

2025
£

2024
£

Trade debtors

11,724

3,828

Other debtors

34,086

45,029

45,810

48,857

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

6

Creditors

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

7

4,768

-

Taxation and social security

 

15,070

12,278

Accruals and deferred income

 

3,835

3,650

 

23,673

15,928

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

7

24,206

-

 

7

Loans and borrowings

Current loans and borrowings

2025
£

2024
£

Hire purchase contracts

4,768

-

Non-current loans and borrowings

2025
£

2024
£

Hire purchase contracts

24,206

-

 

The Equine Eye Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

 

8

Deferred tax

Deferred tax assets and liabilities

2025

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

(145)

(145)

 

9

Share capital

Allotted, called up and fully paid shares

 

2025

2024

 

No.

£

No.

£

Ordinary A of £1 each

99

99

99

99

Ordinary B of £1 each

99

99

99

99

Ordinary C of £1 each

1

1

1

1

Ordinary D of £1 each

1

1

1

1

 

200

200

200

200

The difference classes of share referred to above carry separate rights to dividends but, in all other significant respects, rank pari passu.

 

10

Related party transactions

Key management personnel

Summary of transactions with key management

As at the balance sheet date the company was owed by the directors' of the company £8,220 (2024: £19,434). These amounts are included within other debtors (2024: other debtors). There are no fixed repayment terms and interest is charged on the amount owed to the company.

An analysis of the movement in the amount owed to the company from the directors is as follows:

 

Transactions with directors

2025

At 1 April 2024
£

Advances to director
£

Repayments by director
£

At 31 March 2025
£

Mr T and Mrs M Knott

Director's loan account

19,434

23,410

(34,624)

8,220

2024

At 1 April 2023
£

Advances to director
£

Repayments by director
£

At 31 March 2024
£

Mr T and Mrs M Knott

34,335

15,793

(30,694)

19,434